ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!TLX Company Profile and Key Details
Telix Pharmaceuticals Limited
TLX Stock Price Chart
Stock Price Today
Telix Pharmaceuticals Limited (TLX) stock declined over -1.51%, trading at $19.21 on NASDAQ, down from the previous close of $19.50. The stock opened at $19.40, fluctuating between $19.13 and $19.77 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; and TLX250 for the treatment of clear cell renal cell carcinoma. The company also develops TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning; TLX300 for the treatment of soft tissue sarcoma; and TLX592, a prostate cancer therapy candidate for targeted alpha therapy. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.
Company Information
| Employees | 0 |
| Beta | 2.41 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Telix Pharmaceuticals Limited (NASDAQ: TLX) stock price is $19.21 in the last trading session. During the trading session, TLX stock reached the peak price of $19.77 while $19.13 was the lowest point it dropped to. The percentage change in TLX stock occurred in the recent session was -1.51% while the dollar amount for the price change in TLX stock was -$0.30.
The NASDAQ listed TLX is part of Biotechnology industry that operates in the broader Healthcare sector. Telix Pharmaceuticals Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
TLX's closing price is 37.08% higher than its 52-week low of $14.01 where as its distance from 52-week high of $30.36 is -36.74%.
Number of TLX employees currently stands at 0.
Official Website of TLX is: https://telixpharma.com
TLX could be contacted at phone 613 909 33855 and can also be accessed through its website. TLX operates from 55 Flemington Road, North Melbourne, VIC 3051, Australia.
TLX stock volume for the day was 86.1K shares. The average number of TLX shares traded daily for last 3 months was 22.89K.
The market value of TLX currently stands at $6.43B with its latest stock price at $19.21 and 334.72M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com